Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Social information use and collective foraging in a pursuit diving seabird.

Evans JC, Torney CJ, Votier SC, Dall SRX.

PLoS One. 2019 Sep 23;14(9):e0222600. doi: 10.1371/journal.pone.0222600. eCollection 2019.

2.

Correction to "Codelivery of Paclitaxel and Everolimus at the Optimal Synergistic Ratio: A Promising Solution for the Treatment of Breast Cancer".

Houdaihed L, Evans JC, Allen C.

Mol Pharm. 2019 Oct 7;16(10):4422. doi: 10.1021/acs.molpharmaceut.9b00910. Epub 2019 Sep 23. No abstract available.

PMID:
31545054
3.

In vitro efficacies, ADME, and pharmacokinetic properties of phenoxazine derivatives active against Mycobacterium tuberculosis.

Tanner L, Evans JC, Seldon R, Jordaan A, Warner DF, Haynes RK, Parkinson CJ, Wiesner L.

Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.01010-19. doi: 10.1128/AAC.01010-19. [Epub ahead of print]

PMID:
31427302
4.

A Traumatic Pulseless Electrical Activity Model: Mortality Increases With Hypovolemia Time.

Evans JC, Morgan JD, Castaneda MG, Boudreau SM, Maddry JK, Anderson KL.

J Surg Res. 2019 Nov;243:301-308. doi: 10.1016/j.jss.2019.05.037. Epub 2019 Jun 26.

PMID:
31254903
5.

Characterizing innovators: Ecological and individual predictors of problem-solving performance.

Prasher S, Evans JC, Thompson MJ, Morand-Ferron J.

PLoS One. 2019 Jun 12;14(6):e0217464. doi: 10.1371/journal.pone.0217464. eCollection 2019.

6.

In Vivo Evaluation of Dual-Targeted Nanoparticles Encapsulating Paclitaxel and Everolimus.

Houdaihed L, Evans JC, Allen C.

Cancers (Basel). 2019 May 29;11(6). pii: E752. doi: 10.3390/cancers11060752.

7.

Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer.

Shen YT, Wang L, Evans JC, Allen C, Piquette-Miller M.

Int J Mol Sci. 2019 May 21;20(10). pii: E2498. doi: 10.3390/ijms20102498.

8.

Urbanization and the temporal patterns of social networks and group foraging behaviors.

Jones TB, Evans JC, Morand-Ferron J.

Ecol Evol. 2019 Apr 1;9(8):4589-4602. doi: 10.1002/ece3.5060. eCollection 2019 Apr.

9.

Nutritional and Post-Transplantation Outcomes of Enteral versus Parenteral Nutrition in Pediatric Hematopoietic Stem Cell Transplantation: A Systematic Review of Randomized and Nonrandomized Studies.

Evans JC, Hirani SP, Needle JJ.

Biol Blood Marrow Transplant. 2019 Aug;25(8):e252-e259. doi: 10.1016/j.bbmt.2019.02.023. Epub 2019 Mar 1. Review.

PMID:
30826462
10.

Lipids and polymers in pharmaceutical technology: Lifelong companions.

Siepmann J, Faham A, Clas SD, Boyd BJ, Jannin V, Bernkop-Schnürch A, Zhao H, Lecommandoux S, Evans JC, Allen C, Merkel OM, Costabile G, Alexander MR, Wildman RD, Roberts CJ, Leroux JC.

Int J Pharm. 2019 Mar 10;558:128-142. doi: 10.1016/j.ijpharm.2018.12.080. Epub 2019 Jan 9. Review.

11.

Effects of ambient noise on zebra finch vigilance and foraging efficiency.

Evans JC, Dall SRX, Kight CR.

PLoS One. 2018 Dec 31;13(12):e0209471. doi: 10.1371/journal.pone.0209471. eCollection 2018.

12.

Codelivery of Paclitaxel and Everolimus at the Optimal Synergistic Ratio: A Promising Solution for the Treatment of Breast Cancer.

Houdaihed L, Evans JC, Allen C.

Mol Pharm. 2018 Sep 4;15(9):3672-3681. doi: 10.1021/acs.molpharmaceut.8b00217. Epub 2018 Jun 14. Erratum in: Mol Pharm. 2019 Oct 7;16(10):4422.

PMID:
29863881
13.

BRCA Status Does Not Predict Synergism of a Carboplatin and Olaparib Combination in High-Grade Serous Ovarian Cancer Cell Lines.

Shen YT, Evans JC, Zafarana G, Allen C, Piquette-Miller M.

Mol Pharm. 2018 Jul 2;15(7):2742-2753. doi: 10.1021/acs.molpharmaceut.8b00246. Epub 2018 Jun 1.

PMID:
29750868
14.

Retrospective natural history of thymidine kinase 2 deficiency.

Garone C, Taylor RW, Nascimento A, Poulton J, Fratter C, Domínguez-González C, Evans JC, Loos M, Isohanni P, Suomalainen A, Ram D, Hughes MI, McFarland R, Barca E, Lopez Gomez C, Jayawant S, Thomas ND, Manzur AY, Kleinsteuber K, Martin MA, Kerr T, Gorman GS, Sommerville EW, Chinnery PF, Hofer M, Karch C, Ralph J, Cámara Y, Madruga-Garrido M, Domínguez-Carral J, Ortez C, Emperador S, Montoya J, Chakrapani A, Kriger JF, Schoenaker R, Levin B, Thompson JLP, Long Y, Rahman S, Donati MA, DiMauro S, Hirano M.

J Med Genet. 2018 Aug;55(8):515-521. doi: 10.1136/jmedgenet-2017-105012. Epub 2018 Mar 30.

15.

Priming the tuberculosis drug pipeline: new antimycobacterial targets and agents.

Evans JC, Mizrahi V.

Curr Opin Microbiol. 2018 Oct;45:39-46. doi: 10.1016/j.mib.2018.02.006. Epub 2018 Feb 23. Review.

PMID:
29482115
16.

Ratio-Dependent Synergism of a Doxorubicin and Olaparib Combination in 2D and Spheroid Models of Ovarian Cancer.

Eetezadi S, Evans JC, Shen YT, De Souza R, Piquette-Miller M, Allen C.

Mol Pharm. 2018 Feb 5;15(2):472-485. doi: 10.1021/acs.molpharmaceut.7b00843. Epub 2018 Jan 22.

PMID:
29283581
17.

Cyclodextrin-siRNA conjugates as versatile gene silencing agents.

Malhotra M, Gooding M, Evans JC, O'Driscoll D, Darcy R, O'Driscoll CM.

Eur J Pharm Sci. 2018 Mar 1;114:30-37. doi: 10.1016/j.ejps.2017.11.024. Epub 2017 Nov 27.

PMID:
29191522
18.

Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours.

Evans JC, Malhotra M, Sweeney K, Darcy R, Nelson CC, Hollier BG, O'Driscoll CM.

Int J Pharm. 2017 Oct 30;532(1):511-518. doi: 10.1016/j.ijpharm.2017.09.013. Epub 2017 Sep 13.

PMID:
28916296
19.

Overcoming the Road Blocks: Advancement of Block Copolymer Micelles for Cancer Therapy in the Clinic.

Houdaihed L, Evans JC, Allen C.

Mol Pharm. 2017 Aug 7;14(8):2503-2517. doi: 10.1021/acs.molpharmaceut.7b00188. Epub 2017 May 18. Review.

PMID:
28481116
20.

The Influence of HIV on the Evolution of Mycobacterium tuberculosis.

Koch AS, Brites D, Stucki D, Evans JC, Seldon R, Heekes A, Mulder N, Nicol M, Oni T, Mizrahi V, Warner DF, Parkhill J, Gagneux S, Martin DP, Wilkinson RJ.

Mol Biol Evol. 2017 Jul 1;34(7):1654-1668. doi: 10.1093/molbev/msx107.

21.

Structural properties of the human corpus callosum: Multimodal assessment and sex differences.

Björnholm L, Nikkinen J, Kiviniemi V, Nordström T, Niemelä S, Drakesmith M, Evans JC, Pike GB, Veijola J, Paus T.

Neuroimage. 2017 May 15;152:108-118. doi: 10.1016/j.neuroimage.2017.02.056. Epub 2017 Feb 22.

PMID:
28254453
22.

Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model.

Evans JC, Malhotra M, Fitzgerald KA, Guo J, Cronin MF, Curtin CM, O'Brien FJ, Darcy R, O'Driscoll CM.

Mol Pharm. 2017 Jan 3;14(1):42-52. doi: 10.1021/acs.molpharmaceut.6b00646. Epub 2016 Nov 23.

PMID:
28043128
23.

Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria.

Singh V, Dhar N, Pató J, Kolly GS, Korduláková J, Forbak M, Evans JC, Székely R, Rybniker J, Palčeková Z, Zemanová J, Santi I, Signorino-Gelo F, Rodrigues L, Vocat A, Covarrubias AS, Rengifo MG, Johnsson K, Mowbray S, Buechler J, Delorme V, Brodin P, Knott GW, Aínsa JA, Warner DF, Kéri G, Mikušová K, McKinney JD, Cole ST, Mizrahi V, Hartkoorn RC.

Mol Microbiol. 2017 Jan;103(1):13-25. doi: 10.1111/mmi.13535. Epub 2016 Oct 29.

24.

Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis.

Evans JC, Trujillo C, Wang Z, Eoh H, Ehrt S, Schnappinger D, Boshoff HI, Rhee KY, Barry CE 3rd, Mizrahi V.

ACS Infect Dis. 2016 Dec 9;2(12):958-968. Epub 2016 Oct 5.

25.

Does Gender Influence Colour Choice in the Treatment of Visual Stress?

Conway ML, Evans BJ, Evans JC, Suttle CM.

PLoS One. 2016 Sep 20;11(9):e0163326. doi: 10.1371/journal.pone.0163326. eCollection 2016.

26.

The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Evans JC, Malhotra M, Cryan JF, O'Driscoll CM.

Br J Pharmacol. 2016 Nov;173(21):3041-3079. doi: 10.1111/bph.13576. Epub 2016 Sep 23. Review.

27.

Oligonucleotide conjugates - Candidates for gene silencing therapeutics.

Gooding M, Malhotra M, Evans JC, Darcy R, O'Driscoll CM.

Eur J Pharm Biopharm. 2016 Oct;107:321-40. doi: 10.1016/j.ejpb.2016.07.024. Epub 2016 Aug 10. Review.

PMID:
27521696
28.

Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo.

Evans JC, Malhotra M, Guo J, O'Shea JP, Hanrahan K, O'Neill A, Landry WD, Griffin BT, Darcy R, Watson RW, O'Driscoll CM.

Nanomedicine. 2016 Nov;12(8):2341-2351. doi: 10.1016/j.nano.2016.06.014. Epub 2016 Jul 4.

PMID:
27389146
29.

The Good and Bad of β-Catenin in Kidney Development and Renal Dysplasia.

Boivin FJ, Sarin S, Evans JC, Bridgewater D.

Front Cell Dev Biol. 2015 Dec 22;3:81. doi: 10.3389/fcell.2015.00081. eCollection 2015. Review.

30.

A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor.

Fitzgerald KA, Malhotra M, Gooding M, Sallas F, Evans JC, Darcy R, O'Driscoll CM.

Int J Pharm. 2016 Feb 29;499(1-2):131-145. doi: 10.1016/j.ijpharm.2015.12.055. Epub 2015 Dec 22.

PMID:
26721726
31.

Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis.

Gomatos IP, Halloran CM, Ghaneh P, Raraty MG, Polydoros F, Evans JC, Smart HL, Yagati-Satchidanand R, Garry JM, Whelan PA, Hughes FE, Sutton R, Neoptolemos JP.

Ann Surg. 2016 May;263(5):992-1001. doi: 10.1097/SLA.0000000000001407.

PMID:
26501713
32.

The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis.

Evans JC, Mizrahi V.

Front Microbiol. 2015 Aug 4;6:812. doi: 10.3389/fmicb.2015.00812. eCollection 2015. Review.

33.

Nucleotide Metabolism and DNA Replication.

Warner DF, Evans JC, Mizrahi V.

Microbiol Spectr. 2014 Oct;2(5). doi: 10.1128/microbiolspec.MGM2-0001-2013. Review.

PMID:
26104350
34.

Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro.

Evans JC, McCarthy J, Torres-Fuentes C, Cryan JF, Ogier J, Darcy R, Watson RW, O'Driscoll CM.

Gene Ther. 2015 Oct;22(10):802-10. doi: 10.1038/gt.2015.50. Epub 2015 May 25.

PMID:
26005860
35.

Information use in colonial living.

Evans JC, Votier SC, Dall SR.

Biol Rev Camb Philos Soc. 2016 Aug;91(3):658-72. doi: 10.1111/brv.12188. Epub 2015 Apr 16. Review.

PMID:
25882618
36.

The guanine nucleotide exchange factor (GEF) Asef2 promotes dendritic spine formation via Rac activation and spinophilin-dependent targeting.

Evans JC, Robinson CM, Shi M, Webb DJ.

J Biol Chem. 2015 Apr 17;290(16):10295-308. doi: 10.1074/jbc.M114.605543. Epub 2015 Mar 6.

37.

The complex mechanism of antimycobacterial action of 5-fluorouracil.

Singh V, Brecik M, Mukherjee R, Evans JC, Svetlíková Z, Blaško J, Surade S, Blackburn J, Warner DF, Mikušová K, Mizrahi V.

Chem Biol. 2015 Jan 22;22(1):63-75. doi: 10.1016/j.chembiol.2014.11.006. Epub 2014 Dec 24.

38.

Prevention of degradation of the natural high potency sweetener (2R,4R)-monatin in mock beverage solutions.

Storkey C, Pattison DI, Koehler JA, Gaspard DS, Evans JC, Hagestuen ED, Davies MJ.

Food Chem. 2015 Apr 15;173:645-51. doi: 10.1016/j.foodchem.2014.10.054. Epub 2014 Oct 18.

PMID:
25466071
39.

Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.

Nicholson JA, Greenhalf W, Jackson R, Cox TF, Butler JV, Hanna T, Harrison S, Grocock CJ, Halloran CM, Howes NR, Raraty MG, Ghaneh P, Johnstone M, Sarkar S, Smart HL, Evans JC, Aithal GP, Sutton R, Neoptolemos JP, Lombard MG.

Pancreas. 2015 Mar;44(2):260-5. doi: 10.1097/MPA.0000000000000246.

PMID:
25438071
40.

Phosphorylation of serine 106 in Asef2 regulates cell migration and adhesion turnover.

Evans JC, Hines KM, Forsythe JG, Erdogan B, Shi M, Hill S, Rose KL, McLean JA, Webb DJ.

J Proteome Res. 2014 Jul 3;13(7):3303-13. doi: 10.1021/pr5001384. Epub 2014 Jun 13.

41.

The role of transcription factors in prostate cancer and potential for future RNA interference therapy.

Fitzgerald KA, Evans JC, McCarthy J, Guo J, Prencipe M, Kearney M, Watson WR, O'Driscoll CM.

Expert Opin Ther Targets. 2014 Jun;18(6):633-49. doi: 10.1517/14728222.2014.896904. Epub 2014 Mar 24. Review.

PMID:
24660778
42.

Biophysical and structural characterisation of nucleic acid complexes with modified cyclodextrins using circular dichroism.

O'Mahony AM, Cronin MF, McMahon A, Evans JC, Daly K, Darcy R, O'Driscoll CM.

J Pharm Sci. 2014 May;103(5):1346-55. doi: 10.1002/jps.23922. Epub 2014 Mar 6.

PMID:
24604260
43.

Weighted profile likelihood-based confidence interval for the difference between two proportions with paired binomial data.

Pradhan V, Saha KK, Banerjee T, Evans JC.

Stat Med. 2014 Jul 30;33(17):2984-97. doi: 10.1002/sim.6130. Epub 2014 Mar 6.

PMID:
24599527
44.

Activation of Rac by Asef2 promotes myosin II-dependent contractility to inhibit cell migration on type I collagen.

Jean L, Majumdar D, Shi M, Hinkle LE, Diggins NL, Ao M, Broussard JA, Evans JC, Choma DP, Webb DJ.

J Cell Sci. 2013 Dec 15;126(Pt 24):5585-97. doi: 10.1242/jcs.131060. Epub 2013 Oct 21.

45.

Binomial confidence intervals for testing non-inferiority or superiority: a practitioner's dilemma.

Pradhan V, Evans JC, Banerjee T.

Stat Methods Med Res. 2016 Aug;25(4):1707-17. doi: 10.1177/0962280213498324. Epub 2013 Aug 2.

PMID:
23912232
46.

Delivering RNAi therapeutics with non-viral technology: a promising strategy for prostate cancer?

Guo J, Evans JC, O'Driscoll CM.

Trends Mol Med. 2013 Apr;19(4):250-61. doi: 10.1016/j.molmed.2013.02.002. Epub 2013 Mar 14. Review.

PMID:
23499575
47.

Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics.

Pitceathly RD, Smith C, Fratter C, Alston CL, He L, Craig K, Blakely EL, Evans JC, Taylor J, Shabbir Z, Deschauer M, Pohl U, Roberts ME, Jackson MC, Halfpenny CA, Turnpenny PD, Lunt PW, Hanna MG, Schaefer AM, McFarland R, Horvath R, Chinnery PF, Turnbull DM, Poulton J, Taylor RW, Gorman GS.

Brain. 2012 Nov;135(Pt 11):3392-403. doi: 10.1093/brain/aws231. Epub 2012 Oct 29.

48.

Endoscopic ultrasound-guided choledoco-duodenostomy as an alternative to percutaneous trans-hepatic cholangiography.

Nicholson JA, Johnstone M, Raraty MG, Evans JC.

HPB (Oxford). 2012 Jul;14(7):483-6. doi: 10.1111/j.1477-2574.2012.00480.x.

49.

Off label use of devices and drugs in interventional radiology.

Zvavanjanja RC, Odetoyinbo TO, Rowlands PC, Healey A, Abdelsalam H, Powell S, Evans JC, Hughes ML, Gould DA, McWilliams RG.

Clin Radiol. 2012 Mar;67(3):239-43. doi: 10.1016/j.crad.2011.06.017. Epub 2011 Oct 5.

PMID:
21978818
50.

The ethics of fish welfare.

Evans JC.

J Fish Biol. 2009 Dec;75(10):2872-4. doi: 10.1111/j.1095-8649.2009.02463.x.

PMID:
20738534

Supplemental Content

Loading ...
Support Center